Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis

Rheumatology (Oxford). 2011 Oct;50(10):1732-6. doi: 10.1093/rheumatology/keq413. Epub 2011 Jan 17.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / physiopathology
  • Clinical Trials as Topic
  • Consensus
  • Control Groups*
  • Drug Approval / methods*
  • Drug and Narcotic Control*
  • Drugs, Investigational
  • Europe
  • Humans

Substances

  • Antirheumatic Agents
  • Drugs, Investigational